Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.

Baron F, Efficace F, Cannella L, Willemze R, Vignetti M, Muus P, Marie JP, Ferrero D, Fazi P, La Sala E, Bourhis JH, Fabbiano F, Bosi A, Sborgia M, Martinelli G, Wittnebel S, Trisolini S, Petti MC, Halkes CJM, van der Velden WJFM, de Witte T, Amadori S, Zittoun RA, Suciu S.

Haematologica. 2020 Jan;105(1):e13-e16. doi: 10.3324/haematol.2019.221333. Epub 2019 May 16. No abstract available.

2.

Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.

Cordone I, Marchesi F, Masi S, Summa V, Pisani F, Merola R, Cigliana G, Orlandi G, Gumenyuk S, Palombi F, Romano A, Spadea A, Renzi D, Papa E, Canfora M, Conti L, Petti MC, Mengarelli A.

J Exp Clin Cancer Res. 2016 Mar 19;35:49. doi: 10.1186/s13046-016-0324-0.

3.

Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.

Picardi A, Mengarelli A, Marino M, Gallo E, Benevolo M, Pescarmona E, Cocco R, Fraioli R, Tremante E, Petti MC, De Fabritiis P, Giacomini P.

J Exp Clin Cancer Res. 2015 Sep 11;34:98. doi: 10.1186/s13046-015-0213-y.

4.

Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.

Finsinger P, Breccia M, Minotti C, Carmosino I, Girmenia C, Chisini M, Volpicelli P, Vozella F, Romano A, Montagna C, Colafigli G, Cimino G, Avvisati G, Petti MC, Lo-Coco F, Foà R, Latagliata R.

Ann Hematol. 2015 Feb;94(2):195-200. doi: 10.1007/s00277-014-2197-7. Epub 2014 Sep 4.

PMID:
25186786
5.

High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.

Marchesi F, Mengarelli A, Giannotti F, Tendas A, Anaclerico B, Porrini R, Picardi A, Cerchiara E, Dentamaro T, Chierichini A, Romeo A, Cudillo L, Montefusco E, Tirindelli MC, De Fabritiis P, Annino L, Petti MC, Monarca B, Arcese W, Avvisati G; Rome Transplant Network.

Transpl Infect Dis. 2014 Feb;16(1):158-64. doi: 10.1111/tid.12162. Epub 2013 Nov 12.

PMID:
24215479
6.

A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.

Marchesi F, Cenfra N, Altomare L, Dessanti ML, Mecarocci S, Cerchiara E, Rago A, D'Andrea M, Tomarchio V, Olimpieri OM, Tirindelli MC, Mengarelli A, Petti MC, Avvisati G, Cimino G.

J Geriatr Oncol. 2013 Jul;4(3):242-8. doi: 10.1016/j.jgo.2013.04.003. Epub 2013 May 7.

PMID:
24070462
7.

Cross-recognition of aspergillus galactomannan caused by Listeria monocytogenes infection.

Petti MC, Prignano G, Mengarelli A, Spadea A, Cilli L, Girmenia C.

Diagn Microbiol Infect Dis. 2013 Jun;76(2):250-1. doi: 10.1016/j.diagmicrobio.2013.02.005. Epub 2013 Mar 19.

PMID:
23518185
8.

miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.

Pelosi A, Careccia S, Lulli V, Romania P, Marziali G, Testa U, Lavorgna S, Lo-Coco F, Petti MC, Calabretta B, Levrero M, Piaggio G, Rizzo MG.

Oncogene. 2013 Aug 1;32(31):3648-54. doi: 10.1038/onc.2012.398. Epub 2012 Sep 10.

PMID:
22964640
9.

Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

Hengeveld M, Suciu S, Karrasch M, Specchia G, Marie JP, Muus P, Petti MC, Rotoli B, Amadori S, Fioritoni G, Leoni P, Morra E, Thaler J, Resegotti L, Fazi P, Vignetti M, Mandelli F, Zittoun R, de Witte T.

Ann Hematol. 2012 Jun;91(6):825-35. doi: 10.1007/s00277-012-1436-z. Epub 2012 Mar 31.

10.

IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.

Pisani F, Petrucci MT, Giannarelli D, Bongarzoni V, Montanaro M, De Stefano V, La Verde G, Gentilini F, Levi A, Za T, Moscetti A, Annino L, Petti MC; Multiple Myeloma GIMEMA-Latium Region Working Group, Italy.

J Exp Clin Cancer Res. 2012 Mar 1;31:17. doi: 10.1186/1756-9966-31-17.

11.

The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: a study from the Rome Transplant Network.

Marchesi F, Giannotti F, Avvisati G, Petti MC, Pimpinelli F, Paba P, Dessanti ML, Cerretti R, Tirindelli MC, Picardi A, D'Andrea M, Spadea A, Ensoli F, Perno CF, Mengarelli A, Arcese W.

Am J Hematol. 2012 Feb;87(2):213-7. doi: 10.1002/ajh.22214. Epub 2011 Nov 11.

12.

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.

Breccia M, Mazzarella L, Bagnardi V, Disalvatore D, Loglisci G, Cimino G, Testi AM, Avvisati G, Petti MC, Minotti C, Latagliata R, Foà R, Pelicci PG, Lo-Coco F.

Blood. 2012 Jan 5;119(1):49-54. doi: 10.1182/blood-2011-07-369595. Epub 2011 Nov 2.

PMID:
22049518
13.

Trigeminal neuralgia as unusual isolated symptom of fungal paranasal sinusitis in patients with haematological malignancies.

Maschio M, Mengarelli A, Girmenia C, Vidiri A, Kayal R, Gallo MT, Prignano G, Dessanti ML, D'Andrea M, Petti MC.

Neurol Sci. 2012 Jun;33(3):647-52. doi: 10.1007/s10072-011-0808-9. Epub 2011 Oct 7.

PMID:
21979557
14.

Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.

Nosotti L, D'Andrea M, Pitidis A, Pimpinelli F, Dessanti ML, Pisani F, Vignally P, Petti MC.

Scand J Infect Dis. 2012 Jan;44(1):70-3. doi: 10.3109/00365548.2011.611819. Epub 2011 Sep 12.

PMID:
21905952
15.

GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.

Latagliata R, Breccia M, Fazi P, Vignetti M, Di Raimondo F, Sborgia M, Vincelli D, Candoni A, Salvi F, Rupoli S, Martinelli G, Kropp MG, Tonso A, Venditti A, Melillo L, Cimino G, Petti MC, Avvisati G, Lo-Coco F, Mandelli F; GIMEMA Acute Leukaemia Working Party.

Br J Haematol. 2011 Sep;154(5):564-8. doi: 10.1111/j.1365-2141.2011.08593.x. Epub 2011 Jul 14.

PMID:
21751984
16.

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.

Avvisati G, Lo-Coco F, Paoloni FP, Petti MC, Diverio D, Vignetti M, Latagliata R, Specchia G, Baccarani M, Di Bona E, Fioritoni G, Marmont F, Rambaldi A, Di Raimondo F, Kropp MG, Pizzolo G, Pogliani EM, Rossi G, Cantore N, Nobile F, Gabbas A, Ferrara F, Fazi P, Amadori S, Mandelli F; GIMEMA, AIEOP, and EORTC Cooperative Groups.

Blood. 2011 May 5;117(18):4716-25. doi: 10.1182/blood-2010-08-302950. Epub 2011 Mar 8.

PMID:
21385856
17.

Long-term seventh molecular remission in acute promyelocytic leukaemia.

Cicconi L, Romano A, Ramadan SM, Divona M, Petti MC, Lo-Coco F.

Ann Hematol. 2011 Nov;90(11):1369-70. doi: 10.1007/s00277-011-1189-0. Epub 2011 Feb 19. No abstract available.

PMID:
21336626
18.

FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases.

Pisani F, Maini CL, Sciuto R, Dessanti L, D'Andrea M, Assisi D, Petti MC.

J Exp Clin Cancer Res. 2011 Feb 8;30:16. doi: 10.1186/1756-9966-30-16.

19.

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

Lo-Coco F, Avvisati G, Vignetti M, Breccia M, Gallo E, Rambaldi A, Paoloni F, Fioritoni G, Ferrara F, Specchia G, Cimino G, Diverio D, Borlenghi E, Martinelli G, Di Raimondo F, Di Bona E, Fazi P, Peta A, Bosi A, Carella AM, Fabbiano F, Pogliani EM, Petti MC, Amadori S, Mandelli F; Italian GIMEMA Cooperative Group.

Blood. 2010 Oct 28;116(17):3171-9. doi: 10.1182/blood-2010-03-276196. Epub 2010 Jul 19.

PMID:
20644121
20.

Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.

Romeo A, Chierichini A, Spagnoli A, Vittori M, Vacca M, Gozzer M, Spadea A, Anaclerico B, Dessanti ML, D'Andrea M, Toglia G, Annino L, Petti MC, Mengarelli A, Arcese W; Rome Transplant Network.

Transfusion. 2010 Nov;50(11):2432-46. doi: 10.1111/j.1537-2995.2010.02723.x.

PMID:
20553434
21.

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.

Zinzani PL, Rossi G, Franceschetti S, Botto B, Di Rocco A, Cabras MG, Petti MC, Stefoni V, Broccoli A, Fanti S, Pellegrini C, Montini GC, Gandolfi L, Derenzini E, Argnani L, Fina M, Tucci A, Bottelli C, Pileri S, Baccarani M.

Clin Cancer Res. 2010 Aug 1;16(15):3998-4004. doi: 10.1158/1078-0432.CCR-10-0162. Epub 2010 Jun 11.

22.

Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.

Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC, Meloni G, Muus P, Marmont F, Marie JP, Labar B, Thomas X, Di Raimondo F, Willemze R, Liso V, Ferrara F, Baila L, Fazi P, Zittoun R, Amadori S, de Witte T.

J Clin Oncol. 2009 Nov 10;27(32):5397-403. doi: 10.1200/JCO.2008.20.6490. Epub 2009 Oct 13. Erratum in: J Clin Oncol. 2010 Mar 10;28(8):1438.

23.

Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma.

Derenzini E, Stefoni V, Pellegrini C, Fina MP, Broccoli A, Venturini F, Gandolfi L, Pileri SA, Martelli M, Petti MC, Perrotti A, De Renzo A, Zaja F, Baccarani M, Zinzani PL.

Leuk Lymphoma. 2009 Nov;50(11):1824-9. doi: 10.3109/10428190903216796.

PMID:
19814687
24.

Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results.

Latagliata R, Rago A, Spadea A, Santoro C, Carmosino I, Breccia M, Napoleone L, Fama A, Biondo F, Volpicelli P, Vozella F, Stefanizzi C, Petti MC, Alimena G, Mazzucconi MG.

Int J Hematol. 2009 Nov;90(4):486-491. doi: 10.1007/s12185-009-0401-7. Epub 2009 Aug 22.

PMID:
19701677
25.

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

Voso MT, Santini V, Finelli C, Musto P, Pogliani E, Angelucci E, Fioritoni G, Alimena G, Maurillo L, Cortelezzi A, Buccisano F, Gobbi M, Borin L, Di Tucci A, Zini G, Petti MC, Martinelli G, Fabiani E, Fazi P, Vignetti M, Piciocchi A, Liso V, Amadori S, Leone G.

Clin Cancer Res. 2009 Aug 1;15(15):5002-7. doi: 10.1158/1078-0432.CCR-09-0494. Epub 2009 Jul 28.

26.

The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.

D'Andrea M, Nosotti L, Pimpinelli F, Dessanti ML, Paviglianiti A, Miglioresi L, Morrone A, Petti MC.

Dig Liver Dis. 2009 Nov;41(11):839-40. doi: 10.1016/j.dld.2009.03.002. Epub 2009 May 21. No abstract available.

PMID:
19464241
27.

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.

Greco C, Vitelli G, Vercillo G, Vona R, Giannarelli D, Sperduti I, Pisani F, Capoluongo E, Petti MC, Ameglio F.

J Exp Clin Cancer Res. 2009 Mar 10;28:35. doi: 10.1186/1756-9966-28-35.

28.

Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.

Breccia M, Latagliata R, Carmosino I, Cannella L, Diverio D, Guarini A, De Propris MS, Petti MC, Avvisati G, Cimino G, Mandelli F, Lo-Coco F.

Haematologica. 2008 Dec;93(12):1918-20. doi: 10.3324/haematol.13510. Epub 2008 Oct 22. No abstract available.

29.

Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin.

Pisani F, Marino M, Sentinelli S, Petti MC.

J Exp Clin Cancer Res. 2008 Sep 2;27:33. doi: 10.1186/1756-9966-27-33.

30.

Doppler flowmetry of splenic vessels in lymphoproliferative disorders: preliminary results.

Solivetti F, Spadea A, Brigida R, Pisani F, Petti MC.

J Exp Clin Cancer Res. 2006 Sep;25(3):453-5. No abstract available.

PMID:
17167988
31.

Late relapses in acute promyelocytic leukaemia.

Latagliata R, Carmosino I, Breccia M, Minni A, Testi A, Iorio N, Lo-Coco F, Avvisati G, Petti MC, Mandelli F, Cimino G.

Acta Haematol. 2007;117(2):106-8. Epub 2006 Nov 28.

PMID:
17135723
32.

Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.

Cimino G, Lo-Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Nanni M, Careddu A, Fazi F, Padula F, Fiorini R, Spiriti MA, Petti MC, Venditti A, Amadori S, Mandelli F, Pelicci PG, Nervi C.

Cancer Res. 2006 Sep 1;66(17):8903-11.

33.

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.

Breccia M, Avvisati G, Latagliata R, Carmosino I, Guarini A, De Propris MS, Gentilini F, Petti MC, Cimino G, Mandelli F, Lo-Coco F.

Leukemia. 2007 Jan;21(1):79-83. Epub 2006 Aug 24.

PMID:
16932337
34.

Diffuse large B-cell lymphoma involving the breast. A report of four cases.

Pisani F, Romano A, Anticoli Borza P, Marino M, Micheli A, Botti C, Petti MC.

J Exp Clin Cancer Res. 2006 Jun;25(2):277-81.

PMID:
16918141
35.

NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.

Pagano L, Gallamini A, Trapè G, Fianchi L, Mattei D, Todeschini G, Spadea A, Cinieri S, Iannitto E, Martelli M, Nosari A, Bona ED, Tosti ME, Petti MC, Falcucci P, Montanaro M, Pulsoni A, Larocca LM, Leone G; Intergruppo Italiano Linfomi.

Ann Oncol. 2006 May;17(5):794-800. Epub 2006 Feb 23.

PMID:
16497823
36.

Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon.

Latagliata R, Bongarzoni V, Carmosino I, Mengarelli A, Breccia M, Borza PA, D'Andrea M, D'Elia GM, Mecarocci S, Morano SG, Petti MC, Mandelli F, Alimena G.

Ann Oncol. 2006 Feb;17(2):281-5. Epub 2005 Dec 22.

PMID:
16373393
37.

BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results.

Capria S, Latagliata R, Avvisati G, Breccia M, Cimino G, Diverio D, Petti MC, Meloni G.

Bone Marrow Transplant. 2005 Jul;36(1):83-4. No abstract available.

PMID:
15880128
38.

Multiple relapses and extramedullary localization with scalp and breast involvement in a case of acute promyelocytic leukaemia.

Ammatuna E, Borza PA, Iori AP, Petti MC, Pescarmona E, Diverio D, Lo-Coco F.

Leukemia. 2005 Mar;19(3):479-80. No abstract available.

PMID:
15674358
39.

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome.

Spiriti MA, Latagliata R, Niscola P, Cortelezzi A, Francesconi M, Ferrari D, Volpe E, Clavio M, Grossi A, Reyes MT, Musto P, Mitra ME, Azzarà A, Pagnini D, D'Arena G, Spadano A, Balleari E, Pecorari P, Capochiani E, De Biasi E, Perego D, Monarca B, Pisani F, Scaramella G, Petti MC.

Ann Hematol. 2005 Mar;84(3):167-76. Epub 2004 Nov 30.

PMID:
15592833
40.

Zoledronic acid-associated thrombotic thrombocytopenic purpura.

Ferretti G, Petti MC, Carlini P, Zeuli M, Picardi A, Meloni G, Bria E, Papaldo P, Fabi A, Cognetti F.

Ann Oncol. 2004 Dec;15(12):1847-8. No abstract available.

PMID:
15550592
41.

Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution.

Breccia M, Mandelli F, Petti MC, D'Andrea M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De Fabritiis P, Alimena G.

Leuk Res. 2004 Nov;28(11):1165-9. Review.

PMID:
15380340
42.

Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia.

Cianciulli AM, Marzano R, Merola R, Orlandi G, Petti MC, Guadagni F, Pisani F.

Haematologica. 2004 Sep;89(9):ECR37.

43.

Apoptosis susceptibility and cell-cycle distribution in cells from myelodysplastic syndrome patients: modulatory in-vitro effects of G-CSF and interferon-alpha.

Ricciardi MR, Petrucci MT, Gregorj C, Martini V, Levi A, De Cuia MR, Latagliata R, Petti MC, Mandelli F, Foà R, Tafuri A.

Leuk Lymphoma. 2004 Jul;45(7):1437-43.

PMID:
15359645
44.

Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia.

Carmosino I, Latagliata R, Avvisati G, Breccia M, Finolezzi E, Lo Coco F, Petti MC.

Haematologica. 2004 May;89(5):615-7.

45.
46.

Survival of elderly patients with acute myeloid leukemia.

Pulsoni A, Pagano L, Latagliata R, Casini M, Cerri R, Crugnola M, De Paoli L, Di Bona E, Invernizzi R, Marmont F, Petti MC, Rigolin G, Ronco F, Spadano A, Tosti ME, Visani G, Mele A, Mandelli F.

Haematologica. 2004 Mar;89(3):296-302.

47.

Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.

Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F.

Haematologica. 2004 Jan;89(1):29-33.

48.

High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.

Petti MC, Tafuri A, Latagliata R, Aloe Spiriti MA, Montefusco E, Mancini M, Meloni G, Petrucci MT, Spadea A, Redi R, Alimena G, Mandelli F.

Ann Hematol. 2003 Aug;82(8):476-480. doi: 10.1007/s00277-003-0693-2. Epub 2003 Jun 26.

PMID:
12835916
49.

Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.

Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F, Gobbi M, Nobile F, Gallo E, Fanin R, Amadori S, Vignetti M, Fioritoni G, Ferrara F, Peta A, Giustolisi R, Broccia G, Petti MC, Lo-Coco F; Italian GIMEMA Cooperative Group.

Leukemia. 2003 Jun;17(6):1085-90.

PMID:
12764372
50.

Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count.

Breccia M, Carmosino I, Diverio D, De Santis S, De Propris MS, Romano A, Petti MC, Mandelli F, Lo-Coco F.

Br J Haematol. 2003 Jan;120(2):266-70.

PMID:
12542484

Supplemental Content

Loading ...
Support Center